Delivery Order SPE2DB20D3103-SPE2DB23FN9Z2
Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $1.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,171.85, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 29, 2023. This award is not associated with a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,966.93, is for the delivery of 4563374242 - Oxcarbazepine 300 mg/5 ml Suspension 250 ml. The contract is a Delivery Order with a Firm Fixed Price type and has an ultimate completion date of January 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This is a delivery order under a Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $11,218.95 and a completion date of June 18, 2024. This order is not designated as a set-aside contract. AmerisourceBergen holds a large IDC with the DLA Troop...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Oxcarbazepine 600 mg tablets, a neurological medication, with a ceiling value of $1,792.41 and a performance period through June 2025. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,277.11 contract is for the delivery of 100 units of the medication Oxcarbazepine Extended-Release 300 mg Tablets. The award has an ultimate completion date of May 30, 2025. Amerisourcebergen Drug Corp is the prime contractor and no subcontractors are mentioned. This contract is not designated as a...
- This federal contract award is for the delivery of OXCARBAZEPINE ER 600 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,680.74, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of July 14, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $1,966.04 for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, identified as SPE2DB20D1100|SPE2DB25FB7U5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,552.55 fixed-price delivery order is for the supply of 4567943087 - OXCARBAZEPINE ER 600 MG TABLET 100S, with a completion date of April 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...